Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page
- Check5 days agoChange DetectedAdded revision tag 'Revision: v3.3.4' and removed 'Revision: v3.3.3'; these are administrative version-history updates and do not affect the study details on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded a new Locations section for Västra Götaland County with Gothenburg site details and updated to Revision v3.3.3, replacing the former Västra Götaland County Locations entry.SummaryDifference0.2%

- Check54 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2; no visible changes to study content or layout are evident in the screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedPublications notes were updated to include Revision: v3.3.1 and clarify that publications are provided voluntarily by the person entering information; the previous wording referencing 'the study results' and the older Revision: v3.2.0 were removed.SummaryDifference0.1%

- Check69 days agoChange DetectedThe notice about government funding/status at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedThe PEMDAC study (NCT02697630) is now displayed as Completed with updated dates and reference to study results on the Study Details page.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.